Geographic Atrophy - 34 Studies Found Status Study Completed Study Name: Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Condition: Geographic Atrophy Age-Related Macular Degeneration Date: 2014-05-01 Interventions: Drug: Emixustat HCl Tablet Tab Completed Study Name: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy Condition: Dry Age-related Macular Degeneration Geographic Atrophy Date: 2009-10-26 Interventions: Drug: ACU-4429 ACU-4429 tablet Terminated Study Name: Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration Condition: Age-Related Macular Degeneration Geographic Atrophy Date: 2014-05-12 Interventions: Biological: Human Central Nervous System Stem Cells Other Name: HuCNS-SC Recruiting Study Name: A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (SPECTRI) Condition: Geographic Atrophy Date: 2014-07-15 Interventions: Drug: Lampalizumab 10-mg dose Recruiting Study Name: A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA) Condition: Geographic Atrophy Date: 2014-07-15 Interventions: Drug: Lampalizumab 10-mg dose